FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Ambey Laboratories IPO and Prizor Viztech IPO.
Ambey Laboratories IPO is a SME Book Built Issue IPO proposed to list at NSE SME while Prizor Viztech IPO is a SME Book Built Issue proposed to list at NSE SME.
Ambey Laboratories IPO | Prizor Viztech IPO | |
---|---|---|
Logo | ![]() |
![]() |
Issue Category | SME | SME |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | NSE SME | NSE SME |
Lead Managers | Fast Track Finsec Pvt Ltd | Shreni Shares Limited |
Registrar | Link Intime India Private Ltd | Bigshare Services Pvt Ltd |
Market Maker | Nikunj Stock Brokers Limited | Rikhav Securities Limited |
DRHP | DRHP ![]() |
DRHP ![]() |
RHP | RHP ![]() |
RHP ![]() |
Anchor Investor | Anchor Investor ![]() |
|
IPO Allotment URL |
The total issue size of Ambey Laboratories IPO is up to ₹44.68 Cr whereas the issue size of the Prizor Viztech IPO is . The final issue price of Ambey Laboratories IPO is ₹68.00 per share and of Prizor Viztech IPO is .
Ambey Laboratories IPO | Prizor Viztech IPO | |
---|---|---|
Face Value | ₹10 per share | ₹10 per share |
Issue Price (Lower) | ₹65.00 per share | |
Issue Price (Upper) | ₹68.00 per share | |
Issue Price (Final) | ₹68.00 per share | |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 2000 shares | |
Fresh Issue Size | 62,58,000 shares | 28,91,200 shares |
Fresh Issue Size (Amount) | up to ₹42.55 Cr | |
OFS Issue Size | 3,12,000 shares | |
OFS Issue Size (Amount) | up to ₹2.12 Cr | |
Issue Size Total | 65,70,000 shares | 28,91,200 shares |
Issue Size Total (Amount) | up to ₹44.68 Cr |
Ambey Laboratories IPO opens on Jul 04, 2024, while Prizor Viztech IPO opens on Jul 12, 2024. The closing date of Ambey Laboratories IPO and Prizor Viztech IPO is Jul 08, 2024, and Jul 16, 2024, respectively.
Ambey Laboratories IPO | Prizor Viztech IPO | |
---|---|---|
Anchor Bid Date | Jul 03, 2024 | Jul 11, 2024 |
Issue Open | Jul 04, 2024 | Jul 12, 2024 |
Issue Close | Jul 08, 2024 | Jul 16, 2024 |
Basis Of Allotment (Tentative) | Jul 09, 2024 | Jul 18, 2024 |
Initiation of Refunds (Tentative) | Jul 10, 2024 | Jul 19, 2024 |
Credit of Share (Tentative) | Jul 10, 2024 | Jul 19, 2024 |
Listing date (Tentative) | Jul 11, 2024 | Jul 22, 2024 |
Anchor Lockin End date 1 | Aug 08, 2024 | Aug 17, 2024 |
Anchor Lockin End date 2 | Oct 07, 2024 | Oct 16, 2024 |
Ambey Laboratories IPO P/E ratio is 27.81, as compared to Prizor Viztech IPO P/E ratio of .
Ambey Laboratories IPO | Prizor Viztech IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial | Ambey Laboratories Limited Financial Information (Restated)
|
Prizor Viztech Limited Financial Information (Restated)Prizor Viztech Limited's revenue increased by 155.95% and profit after tax (PAT) rose by 2546.91% between the financial year ending with March 31, 2024 and March 31, 2023.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 94.97% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 69.90% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 27.81 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹171.64 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | 20.80%% | 143.86%% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | 13.14%% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | 0.58 | 1.45 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ₹2.44 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW | 20.80%% | 83.67%% |
In the Ambey Laboratories IPO retail investors (RII) are offered 21,84,000 shares while in Prizor Viztech IPO retail investors are offered 21,84,000 shares. Qualified institutional buyers (QIB) are offered 12,52,000 shares in Ambey Laboratories IPO and in Prizor Viztech IPO.
Ambey Laboratories IPO | Prizor Viztech IPO | |
---|---|---|
Anchor Investor Reserveration | 18,72,000 shares | 8,14,400 shares |
Market Maker Reserveration | 3,30,000 shares | 1,60,000 shares |
QIB | 12,52,000 shares | |
NII | 6,06,001 shares | |
RII | 21,84,000 shares | |
Employee | 0 shares | |
Others | ||
Total | 40,42,001 shares |
Ambey Laboratories IPO subscribed 173.18x in total, whereas Prizor Viztech IPO subscribed .
Ambey Laboratories IPO | Prizor Viztech IPO | |
---|---|---|
QIB (times) | 61.90x | |
NII (times) | 324.22x | |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 195.06x | |
Employee (times) | ||
Other (times) | ||
Total (times) | 173.18x |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|